PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 16: Articles 7501-8000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraceptive use dynamics in Matlab, Bangladesh: does the quality of worker make any difference?
  2. Contraceptive use in Egypt: trends and determinants.
  3. Contraceptive use in Ghana. The role of service availability, quality, and price.
  4. Contraceptive use in the United States: 1982-90.
  5. The contraceptive use of Depo-Provera in U.S. adolescents.
  6. The contraceptive use of depot medroxyprogesterone acetate.
  7. Contraceptives, HIV, and other sexually transmitted diseases. [Anticonceptivos, VIH y otras enfermedades de transmision sexual.]
  8. COPE: client-oriented provider-efficient services. A process and tools for quality improvement in family planning and other reproductive health services.
  9. Correlates of choice of contraceptive methods in Pakistan.
  10. Could a publicity campaign for emergency contraception reduce the incidence of unwanted pregnancy and how would we know if it did?
  11. A cross-sectional survey of condom use in conjunction with other contraceptive methods.
  12. Damage to immunisation programmes from misinformation on contraceptive vaccines.
  13. Data on costs and expenditures on family planning and reproductive health.
  14. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: an incidence study for the period 1980-1993.
  15. Decontamination of contraceptive practice diaphragms and caps.
  16. Decreased bone turnover in oral contraceptive users.
  17. Decreasing the steroid dose in oral contraception and risk of functional ovarian cysts. [Diminution des doses de steroides en contraception orale et risque de kystes ovariens fonctionnels.]
  18. Demand for family planning. [Demanda de planificacion familiar.]
  19. Demographic and Health Surveys Phase III. Model "A" questionnaire with commentary for high contraceptive prevalence countries.
  20. Demographic and Health Surveys Phase III. Model "B" questionnaire with commentary for low contraceptive prevalence countries.
  21. Demographic and sociocultural factors influencing contraceptive use in Uganda.
  22. Demographic and socioeconomic determinants of contraceptive use among urban women in the Melanesian countries in the South Pacific: a case study of Port Vila Town in Vanuatu.
  23. Depo Provera contraceptive. Updated 1/95.
  24. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
  25. Designing an appropriate mix of sources for contraceptive methods and services.
  26. Desired number of children and family planning in East and West Germany. [Kinderwunsch und Familienplanung in Ost- und Westdeutschland.]
  27. Despite desire for smaller families, few Ghanaians practice contraception.
  28. Despite Jamaica's high contraceptive prevalence rate, more than two-thirds of pregnancies are unintended.
  29. Determinants of contraceptive method choice in rural Bangladesh.
  30. Determinants of current contraceptive use at the regional level, Egypt, 1991.
  31. Determining an appropriate contraceptive method mix.
  32. Developing countries show sizable cross-national variations in unmet need, demand for contraception.
  33. The development and evolution of the family planning situation analysis methodology.
  34. Development and psychometric testing of an instrument to measure adolescent sexual activity and contraceptive use.
  35. Development of approaches to community based family planning outreach in Egypt: assessment of Raidats Rifiats programs. Final report. Sub-Contract no. C.194.02A.
  36. Development of contraceptive vaccines for humans using antigens derived from gametes (spermatozoa and zona pellucida) and hormones (human chorionic gonadotrophin): current status.
  37. Diabetes mellitus: epidemiological study on fertility, contraception and sterility. [Diabetes mellitus -- Epidemiologische Studie zu Fertilitat, Kontrazeption und Sterilitat.]
  38. The diaphragm: barrier contraception has a new social role.
  39. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
  40. Diffusion of the culture of contraception: program effects on young women in rural Bangladesh.
  41. Direct and judgmental measures of family planning program inputs.
  42. District level baseline survey of family planning program in Uttar Pradesh. Agra.
  43. Do teenagers consult general practitioners for contraceptive advice?
  44. Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?
  45. Does nature know best? Background and mechanisms of natural family planning.
  46. Does utilization of MCH services influence subsequent contraceptive use? Evidence from Morocco.
  47. Dramatic recent decline in fertility in Bangladesh is matched by substantial rise in contraceptive use.
  48. Drs. Thomas and Noonan reply re "Comparison of Recalled and Validated Oral Contraceptive Histories" [letter]
  49. Dynamic period coding in event history analysis: a method of family planning program evaluation.
  50. The dynamics of the diffusion of information and adoption of contraception in Costa Rica.
  51. The economic value of contraception: a comparison of 15 methods.
  52. The economics of family planning services [editorial]
  53. The economics of family planning services.
  54. Ectopic pregnancies after hormonal postcoital contraception. [Extrauteringraviditaten nach hormoneller Postkoitalkontrazeption.]
  55. Education as an indicator of women's status and its impact on fertility and contraception in Pakistan. A multivariate analysis.
  56. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  57. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism.
  58. The effect of sex education on transitions in contraceptive use among teenagers.
  59. Effect of sex, menstrual cycle phase, and oral contraceptive use on circadian temperature rhythms.
  60. The effect of the sex of interviewers on the quality of data in a Nigerian family planning questionnaire.
  61. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
  62. The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
  63. The effectiveness of barrier methods of contraception in preventing the spread of HIV.
  64. The effects of "Twende na Wakati", an entertainment-education radio soap opera for family planning and HIV / AIDS prevention in Tanzania. A progress report on the first year of broadcasting (1993-1994) "Twende na Wakati".
  65. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
  66. The effects of fertility intentions and access to services on contraceptive use in Tunisia.
  67. Effects of lactation and contraceptive use on birth-spacing in Bolivia.
  68. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
  69. Effects of oral contraceptives on fibrinolytic response to exercise.
  70. Effects of postpartum psychiatric illnesses on family planning.
  71. The effects of two phasic oral contraceptives on hemostasis and platelet function.
  72. Efficacy of emergency contraception. Topical reviews.
  73. Egypt. Continuation of contraceptive and service use: the CSI project experience.
  74. Eight million women have unmet need for family planning in Uttar Pradesh.
  75. Emergency contraception [letter]
  76. Emergency contraception - why women don't use it.
  77. Emergency Contraception Hotline, 1-800-584-9911. Fact sheet.
  78. Emergency contraception in GUM clinics [letter]
  79. Emergency contraception provision in the UK.
  80. Emergency contraception. General practitioner knowledge, attitudes and practices in New South Wales.
  81. Emergency contraception: the nation's best-kept secret.
  82. Emergency contraception: guidelines for doctors. Drawn up on behalf of the Faculty of Family Planning and Reproductive Health Care of the Royal College of Obstetricians and Gynaecologists [RCOG]
  83. Emergency contraception: the answer to America's unplanned pregnancy problem? Issue brief.
  84. The emergency contraceptive pill: a survey of knowledge and attitudes among students at Princeton University.
  85. Emergency hormonal post-coital contraception: an integrative review of the literature.
  86. An empirical study of the transactional price of an expected child and its significance to further birth control.
  87. Empowering women: analyses. Legal and policy barriers to family planning.
  88. Endometrial effects of RU486 in normally cycling women may offer new contraceptive strategies.
  89. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
  90. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
  91. Enlarged follicles in women using oral contraceptives.
  92. Epidemiological study on the association between oral contraceptives and female hyperlipemia and hypertension.
  93. Estimating family planning target population of Egypt in 1997.
  94. Estrogens. Contraceptive therapy. [Estrogenos. Terapia anticonceptiva.]
  95. Ethics, family planning, status of women, and the environment.
  96. Ethinylestradiol from contraceptive formulations and the ovarian response: an estrogen dose-dependency on natural estradiol concentrations.
  97. Ethiopian Aid Family Planning and MCH Pilot Project. Gender and Adolescent Project.
  98. Ethnic differences in contraceptive use in Kuwait: a clinic-based study.
  99. EU agency asks for more data on oral contraceptives.
  100. The European Fertility and Family Planning Survey in Hungary. [Europai Temekenysegi es Csaladvizsgalat Magyarorszagon.]
  101. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
  102. Evaluating a designated family planning clinic within a genitourinary medicine clinic.
  103. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
  104. Evaluation of knowledge and skills of field level workers of health and family planning programmes.
  105. Evaluation of mobile education and service units in increasing accessibility and acceptability of family planning methods, India. Final report.
  106. Evaluation of the Centre for Development and Population Activities (CEDPA) Access to Family Planning through Women Managers Project (936-3059)
  107. Evaluation of the impact of family planning programmes on fertility in rural areas of Egypt (1980-1991)
  108. Evaluation of the quality of care in family planning services. [La evaluacion de la calidad de la atencion en los servicios de planificacion familiar.]
  109. Evolution of a new approach to assess the impact of family planning programme on fertility in different states of India: a macro level study.
  110. The evolution of contraceptive methods and practices to the year 2000.
  111. The evolution of private sector involvement in the Indonesian family planning program: transfer of responsibility from the government to the people.
  112. An examination of the fertility/contraceptive prevalence anomaly in Zimbabwe.
  113. Expanding access to emergency contraception in developing countries.
  114. Expanding contraceptive choices for men and women.
  115. Experience with contraceptive implants: removal technique, classification of difficulties and the importance of correct placement.
  116. Experience with the DMPA injectable contraceptive: a comparison between continuing-users and drop-outs, Philippines. Final report.
  117. Experience with the DMPA injectable contraceptive: findings from a survey of DMPA acceptors, Philippines. Final report.
  118. Factor V Leiden mutation, venous thromboembolism and combined oral contraceptive usage.
  119. Factors affecting the dissemination of information about emergency contraceptive pills within government-funded family planning programs.
  120. Factors influencing family planning use in Ilorin, Nigeria.
  121. Factors predicting contraceptive use among adolescents in Zimbabwe.
  122. Factors underlying unmet need for family planning in the Philippines.
  123. Facts about teenage pregnancy, sexually transmitted disease, and birth control.
  124. Family planning among indigenous populations in Latin America.
  125. Family planning and abortion in the Russian Federation. The Russia Longitudinal Monitoring Survey 1992-94.
  126. Family planning and achievement of desired family size.
  127. Family planning and AIDS knowledge, attitude and practice in ten districts of Uganda. Results of focus group discussions and in-depth interviews.
  128. Family planning and reproductive health in CCEE / NIS.
  129. Family planning and sexually transmitted diseases: the need to enhance contraceptive choice.
  130. Family planning and the controversial contraceptives.
  131. Family planning and women's lives: the Malaysian case.
  132. Family planning as a promoter of child survival and growth.
  133. Family planning communication experiences in Peru. [Experiencias de comunicacion en planificacion familiar en el Peru.]
  134. Family planning counseling: a curriculum prototype. Participant's handbook.
  135. Family planning counseling: a curriculum prototype. Trainer's manual.
  136. Family planning in a Roman Catholic community.
  137. Family planning in Aragon. [Planificacion familiar en Aragon.]
  138. Family planning in China. Analyses, data, documents. [Geburtenplanung in China. Analysen, Daten, Dokumente.]
  139. Family planning in genitourinary medicine: an opportunistic service?
  140. Family planning in Latvia: a blossoming flower.
  141. Family planning in Navarre: a personal and casual note. [La P.F. en Navarra: un apunte personal y hasta desenfadado.]
  142. Family planning in Palpa district, Nepal.
  143. Family planning in Russia in 1993-94: the role of NGOs in demonopolising population policy.
  144. Family planning in Sub-Saharan Africa: present status and future strategies.
  145. Family planning in the 1990's: a new era.
  146. Family planning in UP -- an IEC perspective. Literature review.
  147. Family planning in Upper Egypt.
  148. Family planning in Vietnam: women's experiences and dilemmas. A community study from the Red River Delta.
  149. Family planning injections in Egypt (report of the preliminary study)
  150. Family planning knowledge and practice among Nigerian women attending an antenatal clinic.
  151. Family planning logistics guidelines. [Directives de logistique pour la planification familiale.]
  152. Family planning management terms: a pocket glossary in three languages.
  153. Family planning operations research and program evaluation literature review: a selected annotated bibliography: Pakistan 1968-1993.
  154. Family planning outreach and credit programs in rural Bangladesh.
  155. Family planning practices and attitudes among former Soviet new immigrant women in Israel.
  156. The family planning programme: in need of a positive image.
  157. Family planning projections analysis, Kenya 1989-2020.
  158. Family planning rarely available for refugees.
  159. Family planning services in Devon, UK: awareness, experience and attitudes of pregnant teenagers.
  160. Family planning services in the United States.
  161. Family planning training manual. [Manual de orientacion en planificacion familiar.]
  162. Family planning under the Doi Moi policy.
  163. Family planning up a gum tree -- the integration of family planning and genitourinary services in Australia and New Zealand.
  164. Family planning with male involvement.
  165. Family planning, economic constraints and the fertility transition: the case of Mwanga and Moshi urban districts, Tanzania.
  166. Family planning, managed care, and rural America.
  167. Family planning, USA. Airing responsibility; funding controversy.
  168. Family planning. [Planification familiale.]
  169. Family planning. [Planification familiale.]
  170. Family planning: an essential component of prenatal care.
  171. Family planning: personal and political perspectives from Choiseul Province, Solomon Islands.
  172. Family size desire, sex preference, socio-economic condition and contraceptive use in rural Karnataka, India.
  173. Features of present-day contraceptive behavior (according to the data from the Tver district) [Osobennosti sovremennoi kontratseptivnoi praktiki (po materialam Tverskoi oblasti)]
  174. Features of present-day contraceptive behavior (according to the data of the Tver district) [Osobennosti sovremennoi kontratseptivnoi praktki (po materialam Tverskoi oblasti)]
  175. Female adolescent contraception.
  176. Female adolescents' perceptions of benefits of and barriers to using oral contraceptives.
  177. Feminism, social policy, and long-acting contraception.
  178. Fertility and contraceptive practice in metropolitan Buenos Aires: new data, new questions. [Fecundidad y practica anticonceptiva en el Conurbano de Buenos Aires: nuevos datos, nuevos interrogantes.]
  179. Fertility and family planning behavior linked to residence in Egypt.
  180. Fertility and family planning in African cities: the impact of female migration.
  181. Fertility decline in China and family planning programs. [Syntyvyyden pieneneminen Kiinassa ja Kiinan perhesuunnitteluohjelmat.]
  182. The fertility effect of public family planning expenditures.
  183. Fertility of rural China: effects of local family planning and health programs.
  184. The fight for reproductive rights in Central and Eastern Europe. Albania: discovering the human right to family planning.
  185. Final evaluation of the CARE Population and Family Planning Expansion (PFPE) project.
  186. Final evaluation of the Contraceptive Research and Development Program (CONRAD) (936-3044)
  187. Final evaluation of the Ghana Family Planning and Health Project (FPHP) (641-0118)
  188. Final report. The Image of Service Providers and Contraceptive Methods in Uttar Pradesh, India. Sub-agreement between the Johns Hopkins University Population Communication Services and the Social and Rural Research Institute, April 11, 1994 - February 15, 1995, AS-IND-05.
  189. Final report: A Comparative Study of Three Strategies to Improve the Sustainability of a Bolivian Family Planning Provider, Centro de Investigacion, Educacion y Salud (CIES). Contract number CI92.26A and CI94.25A, July 1, 1992 - July 31, 1994.
  190. Final report: Family Planning / Maternal Child Health (FP/MCH) Radio Audience Study. JHU / PCS Project No.: AS-NEP-05, May 15, 1992 - February 15, 1993. Audience study conducted by New ERA for the Johns Hopkins University Population Communication Services.
  191. Final report: Increasing Access to Family Planning Services in Rural Campesino Communities: a Pilot Project. CCH (Community and Child Health), Contract Number CI93.56A. July 15, 1993 - September 14, 1994.
  192. Final report: Private Sector Family Planning Project, 1991-1995. Contraceptive prevalence and self-sufficiency in Indonesia: the contributions of the Private Sector Family Planning Project.
  193. Final report: Situation Analysis of Village Based Family Planning Workers, 1995.
  194. Findings from the Sub-Saharan Africa Urban Family Planning Study. Blantyre city report.
  195. Findings from the Sub-Saharan Africa Urban Family Planning Study. Bulawayo city report.
  196. Findings from the Sub-Saharan Africa Urban Family Planning Study. Mombasa city report.
  197. Flawed research does not permit valid inferences about Cu-7 intrauterine contraceptive device. Reply [letter]
  198. The focus group: is this an acceptable method of exploring women's knowledge of the oral contraceptive?
  199. Future contraceptives.
  200. Future prospects in contraception. [Zukunftsperspektiven der Empfangisverhutung.]
  201. Gastrointestinal disease and oral contraception. [Enfermedad gastrointestinal y anticoncepcion oral.]
  202. Gender differences in perceptions and valuations of contraceptive characteristics.
  203. Gender, female clients and family planning service providers in Quito. [Genero, cliente femenino y los proveedores del servicios de planificacion familiar en Quito.]
  204. A genetic male infant with female phenotype in camptomelic syndrome: a possible relationship to exposure to oral contraceptives during pregnancy.
  205. Geographical and medical barriers to family planning services in rural Jamaica.
  206. Geographical differences in contraceptive behavior. [Les contrastes geographiques des comportements de contraception.]
  207. Gestodene-containing contraceptives.
  208. Gestodene: a review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.
  209. The Global Initiative on Contraceptive Requirements and Logistics Management Needs--lessons and methodologies.
  210. A great thing for poor folks: birth control, sterilization, and abortion in public health and welfare in the twentieth century.
  211. A guest editorial: over-the-counter oral contraceptives: an idea whose time has not quite come] [editorial]
  212. Gynefix intrauterine implant systems for interval, postplacental, and postabortal contraception. International Working Group on Intrauterine Drug Delivery.
  213. Handbook of family planning and reproductive health care. 3rd.
  214. Handbook of family planning standards. [Manual de normas de planificacion familiar.]
  215. Health benefits of family planning.
  216. Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: an open, randomized, parallel-group study.
  217. His or hers: the choice of contraceptive sterilization among married couples in the U.S.
  218. A history of oral contraception: from evolution to revolution.
  219. HIV / STD prevention in family planning services: training as a strategy for change.
  220. HIV prevention and family planning: integration improves client services in Jamaica.
  221. Hormonal contraception and HIV [editorial]
  222. Hormonal contraception and platelet function.
  223. Hormonal implant is more effective among teenagers than oral contraceptives.
  224. Hormonal male contraception: progress and prospects for the 21st century.
  225. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
  226. How effective are family planning programs? The evidence from true experiments.
  227. How family planning services fare under state bids to restructure Medicaid.
  228. How has international population policy been formulated? The role and positioning of family planning]
  229. How we can save Norplant contraceptive implants. Trouble in paradise?
  230. Ictus, pregnancy and contraception. [Ictus, embarazo y contracepcion.]
  231. Identification of success indicators of management and implementation aspects of government and non-government family planning programs.
  232. Identifying barriers to the use of appropriate methods of contraception.
  233. Image and the adoption of contraceptive behavior: impact of the Philippine national communication campaign.
  234. IMAP on emergency contraception. Statement developed by the International Medical Advisory Panel to IPPF (IMAP), 1994.
  235. Immune cells on intrauterine contraceptive devices.
  236. The impact of an increase in family planning services on the teenage population of Philadelphia.
  237. The impact of characteristics of township network units and of cadres on family planning effectiveness.
  238. Impact of IMA family planning training in Uttar Pradesh.
  239. The impact of knowledge of human immunodeficiency virus serostatus on contraceptive choice and repeat pregnancy.
  240. The impact of oral contraception on vulvovaginal candidiasis.
  241. The impact of policy and program on fertility in Egypt: the Egyptian family planning success story.
  242. The impact of recent policy changes on fertility, abortion, and contraceptive use in Romania.
  243. Impact of some demographic variables and family planning programme on fertility in Madhya Pradesh through indirect techniques.
  244. The impact of using maternal health services on contraceptive use in Egypt, 1991.
  245. The impact of women's rural-urban migration on family planning in Tanzania.
  246. The impact on fertility of contraceptive failure in China in the 1980s.
  247. Implantable hormonal contraceptives: emerging controversy [letter]
  248. Implantable hormonal contraceptives: emerging controversy. In reply [letter]
  249. Implantable levonorgestrel contraception: 4 years of experience with Norplant.
  250. Implementation of DOH training courses for family planning providers in Cagayan Valley.
  251. Implementing the ICPD Plan of Action in Central Asian Republics and Kazakhstan (CARAK). Azerbaijan. Urgent need for family planning.
  252. An important family planning programme.

     

  253. Improving access to quality care in family planning. Medical eligibility criteria for initiating and continuing use of contraceptive methods: combined oral contraceptives (COCs), emergency contraception pills (ECPs), combined injectable contraceptives (CICs), progestogen-only pills (POPs), depot medroxyprogesterone acetate (DMPA), norethisterone enanthate (Net-En), Norplant implants (NOR), copper IUDs (CU IUDs), levonorgestrel IUD (LNG-20 IUD), emergency contraceptive use of IUDs, male sterilization, female sterilization, natural family planning methods (NFP), barrier methods, and lactational amenorrhea method (LAM)
  254. Improving community based family planning services and the potential for increasing contraceptive prevalence in Bangladesh.
  255. Improving reproductive health: integrating STD and contraceptive services.
  256. Inconsistent contraceptive use among female college students: implications for intervention.
  257. Increasing male involvement in the Family Planning Association of Kenya (FPAK) family planning program.
  258. India urged to rethink family planning programme.
  259. India. Mobile teams in India integrate MCH and family planning services.
  260. Indications and contraindications of contraception: a new approach. [Indications et contre-indications de la contraception: nouvelle approche.]
  261. Indonesia. A situation analysis of public family planning clinics: Indonesia.
  262. Indonesia. Enhancing the family planning client's knowledge of a method increases satisfaction.
  263. Indonesia. Population and family planning in fact. 1995/1996. [Indonesia. Kependudukan dan keluarga berencana dalam fakta, 1995/1996.]
  264. Influence of age at marriage and family planning on fertility.
  265. The influence of family and friends' basic conditioning factors and self-care agency on unmarried teenage primiparas' engagement in contraceptive practice.
  266. Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors.
  267. The influence of quality of care upon contraceptive use in rural Bangladesh.
  268. The influence of sex partners on contraceptive use among hig risk and HIV+ women.
  269. Information leaflets on contraception [letter]
  270. Information, education, and communications in the Indonesian family planning program.
  271. Informed contraceptive choice: interview with Vice Minister Li Honggui.
  272. Initial expenditures for contraceptive methods may belie their cost-effectiveness over time.
  273. Injectable contraception and lactation [letter]
  274. Innovations in Family Planning Services (IFPS) project.
  275. Inservice training in client-oriented family planning services for lady health visitors and auxiliary nurse midwives. An assessment of training needs and a strategy for implementing change.
  276. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
  277. The integrated approach: important reforms in China's family planning work.
  278. Integrating essential public health services and managed care. Family planning and reproductive health as a case study.
  279. Integrating reproductive health including family planning and sexual health in community education programmes. Follow-up to ICPD: seventh ICEA conference.
  280. Integrating reproductive health services into family planning programs.
  281. Integrating services helps increase second family planning visits.
  282. Integrating sexually transmitted disease (STD) services in an existing family planning program: the experience of the Salvadoran Demographic Association.
  283. Intrauterine devices are safe and effective contraceptives for type I diabetic women. Further evidence [letter]
  284. Introducing family planning benefits in a Zimbabwean medical aid society: a case study of factors influencing change.
  285. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
  286. An investigation of alternative approaches to contraceptive logistics management at the peripheral level. Final report. Program for the Introduction and Adaptation of Contraceptive Technology, Bangladesh (PIACT, Bangladesh)
  287. Involving a traditional community in strategic planning: the Navrongo Community Health and Family Planning Project Pilot Study.
  288. Is family planning an economic decision?
  289. Is it possible to improve access to family planning through mobile teams? Looking at two approaches from the region. Egypt and India.
  290. Is there a link between fertility decline and family planning in Kenya?
  291. It's your right: promoting continued use of family planning in Kenya.
  292. IUD most effective post-coital contraception.
  293. IUSSP activities. Committee on Fertility and Family Planning. Research Programme, Liege, Belgium, May 25-27, 1995.
  294. Japanese government takes steps toward approving birth control pill.
  295. Kaiser / Harris and Kaiser / Fact Finders national public and provider surveys on emergency contraceptive pills -- the "morning-after" pill. Public knowledge / attitudes and ob / gyn practices / attitudes. [Press release]
  296. Kaiser Family Foundation 1995 Survey of Obstetrician / Gynecologists on Contraception and Unplanned Pregnancy: Attitudes and Practices with Regard to Abortion. Questionnaire and topline data.
  297. The Kaiser Survey on Public Knowledge and Attitudes on Contraception and Unplanned Pregnancy 1995.
  298. KAP Survey on Fertility and Contraception in Cambodia.
  299. Key indicators for family planning projects.
  300. Key informant perceptions of family planning education in Vanuatu.
  301. Knowledge and perceptions of emergency contraceptive pills among a college-age population: a qualitative approach.
  302. Knowledge, attitude and practice of family planning among senior high school students in north Gonder.
  303. Knowledge, attitude and practice of family planning in rural communities in Nigeria.
  304. Knowledge, attitudes and practice of the DMPA injectable contraceptive: data from focus group discussions. Philippines. Final report.
  305. Labeling guidance text for progestin-only oral contraceptives.
  306. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans.
  307. Late start for emergency contraception in Sweden.
  308. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
  309. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
  310. Liberating the shackled half. Family planning in Pakistan.
  311. Liver tumors in women using hormonal contraceptives. [Lebertumoren bei Frauen unter Anwendung von oralen hormonalen Kontrazeptiva -- Kurzmitteilung.]
  312. Local production of contraceptives.
  313. The logic and impact of integrated family planning programmes in Tanzania.
  314. Logistics systems in support of reproductive health and family planning.
  315. Long-acting contraception: moral choices, policy dilemmas.
  316. Long-acting contraception: moral choices, policy dilemmas.
  317. Long-acting contraceptives: ethical guidance for policymakers and health care providers.
  318. Long-acting contraceptives: rationale, current development, and ethical implications.
  319. Long-term contraceptives in the criminal justice system.
  320. Long-term use of hormonal contraceptive DMPA not linked to breast cancer.
  321. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer. News release.
  322. Loops and roots: the conflict between official and traditional family planning in India.
  323. Low levels of family planning knowledge and use threaten Madagascar population goals.
  324. Low-dose oral contraceptives are safer than high-dose pills [letter]
  325. Low-dose oral contraceptives are safer than high-dose pills. Reply [letter]
  326. Low-dose progestogen contraception and the nursing mother.
  327. Lowering of steroid doses in oral contraceptives and risk of functional ovarian cysts. [Diminution des doses de steroides en contraception orale et risque de kystes ovariens fonctionnels.]
  328. Malawi's population and family planning programme. A background briefing document for use by the Malawi government delegation to the United States of America.
  329. The male at family planning clinics: the new patient?
  330. Male CBD agents effective at reaching men with family planning messages.
  331. Male contraception by testicular heating. [Contraception masculine par hyperthermie.]
  332. Male contraception. [La contraception masculine.]
  333. Male involvement in reproductive health, including family planning and sexual health.
  334. The male role in family planning: what do we know?
  335. Management information system for reproductive health / family planning: myths and realities.
  336. Management of genital infection in women attending family planning clinics in the North West of England.
  337. Management of the family planning logistics system: a job reference manual.
  338. Market vendor distribution of contraceptives in Nigeria: a synthesis of experience and achievements.
  339. Maximizing efforts for young women's needs: the role of family planning associations.
  340. Measuring Adherence of Service Providers to the National Maternal and Child Health / Family Planning Service Guidelines. Final report, the Ministry of Public Health.
  341. Measuring the effect of quality of services on contraceptive use in Morocco.
  342. Meeting health and family planning needs in Latin America and the Caribbean.
  343. Meeting reproductive goals: the impact of the quality of family planning services on unintended pregnancy in Peru.
  344. Megaloblastic changes in the cervical epithelium associated with oral contraceptives and changes after treatment with folic acid.
  345. Men and family planning in Bangladesh: a review of the literature. Draft.
  346. Men at family planning clinics: the new patients?
  347. Men's attitudes toward family planning.
  348. Men's contraception injections match pill's effectiveness]
  349. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.
  350. Metabolic and vascular risks of oral contraception. [Risques metaboliques et vasculaires de la contraception orale.]
  351. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
  352. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
  353. Midterm evaluation of the Ecuador Health and Family Planning Project (518-0084)
  354. Midterm evaluation of the Georgetown University Institute for Reproductive Health Initiatives in Natural Family Planning and Breastfeeding Project (936-306)
  355. Mifepristone (RU486) and emergency contraception [letter]
  356. Migraine and combined oral contraceptives -- a response to the joint statement.
  357. Migration and the future of family planning in Tanzania.
  358. The missing method. AIDS and contraception.
  359. Mobile family planning units. [Brigadas moviles.]
  360. Model further analysis plan: contraceptive use dynamics.
  361. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
  362. A multicentred Phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and side effects.
  363. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  364. Mycobacterium abscessus infection of a Norplant contraceptive implant site.
  365. National Family Health Survey (MCH and Family Planning), Andhra Pradesh, 1992.
  366. National Family Health Survey (MCH and Family Planning), Andhra Pradesh, 1992. Summary report.
  367. National Family Health Survey (MCH and Family Planning), Assam, 1992-93.
  368. National Family Health Survey (MCH and Family Planning), Assam, 1992-93. Summary report.
  369. National Family Health Survey (MCH and Family Planning), Bihar, 1993.
  370. National Family Health Survey (MCH and Family Planning), Bihar, 1993. Summary report.
  371. National Family Health Survey (MCH and Family Planning), Delhi, 1993.
  372. National Family Health Survey (MCH and Family Planning), Delhi, 1993. Summary report.
  373. National Family Health Survey (MCH and Family Planning), Goa, 1992-93, summary report.
  374. National Family Health Survey (MCH and Family Planning), Goa, 1992-93.
  375. National Family Health Survey (MCH and Family Planning), Gujarat, 1993.
  376. National Family Health Survey (MCH and Family Planning), Gujarat, 1993. Summary report.
  377. National Family Health Survey (MCH and Family Planning), Haryana, 1993.
  378. National Family Health Survey (MCH and Family Planning), Haryana, 1993. Summary report.
  379. National Family Health Survey (MCH and Family Planning), Himachal Pradesh, 1992.
  380. National Family Health Survey (MCH and Family Planning), Himachal Pradesh, 1992. Summary report.
  381. National Family Health Survey (MCH and Family Planning), India, 1992-93.
  382. National Family Health Survey (MCH and Family Planning), India, 1992-93. Summary report.
  383. National Family Health Survey (MCH and Family Planning), Jammu Region of Jammu and Kashmir, 1993.
  384. National Family Health Survey (MCH and Family Planning), Jammu Region of Jammu and Kashmir, 1993. Summary report.
  385. National Family Health Survey (MCH and Family Planning), Karnataka, 1992-93, summary report.
  386. National Family Health Survey (MCH and Family Planning), Karnataka, 1992-93.
  387. National Family Health Survey (MCH and Family Planning), Kerala, 1992-93.
  388. National Family Health Survey (MCH and Family Planning), Kerala, 1992-93. Summary report.
  389. National Family Health Survey (MCH and Family Planning), Madhya Pradesh, 1992.
  390. National Family Health Survey (MCH and Family Planning), Madhya Pradesh, 1992. Summary report.
  391. National Family Health Survey (MCH and Family Planning), northeastern states (Arunachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland and Tripura), 1993.

     

  392. National Family Health Survey (MCH and Family Planning), Orissa, 1993.
  393. National Family Health Survey (MCH and Family Planning), Orissa, 1993. Summary report.
  394. National Family Health Survey (MCH and Family Planning), Punjab, 1993.
  395. National Family Health Survey (MCH and Family Planning), Punjab, 1993. Summary report.
  396. National Family Health Survey (MCH and Family Planning), Rajasthan, 1992-93.
  397. National Family Health Survey (MCH and Family Planning), Rajasthan, 1992-93.
  398. National Family Health Survey (MCH and Family Planning), West Bengal, 1992.
  399. National Family Health Survey (MCH and Family Planning), West Bengal, 1992. Summary report.
  400. National Family Health Survey (MCH and Family Planning). Arunachal Pradesh, 1993. Summary report.
  401. National Family Health Survey (MCH and Family Planning). Manipur, 1993. Summary report.
  402. National Family Health Survey (MCH and Family Planning). Meghalaya, 1993. Summary report.
  403. National Family Health Survey (MCH and Family Planning). Mizoram, 1993. Summary report.
  404. National Family Health Survey (MCH and Family Planning). Nagaland, 1993. Summary report.
  405. National Family Health Survey (MCH and Family Planning). Tripura, 1993. Summary report.
  406. National Family Health Survey reveals 40 per cent women use contraceptives.
  407. National Family Health Survey throws new light on fertility trends and family planning practices.
  408. National medical standard for reproductive health. Volume I: Contraceptive services.
  409. A national survey of women's attitudes toward oral contraception and other forms of birth control.
  410. Natural family planning (NFP) in medical practice --cooperation with professional counselors. [Naturliche Familienplanung (NFP) in der arzthichen Praxis --Kooperation mit ausgebildrwn Beratern.]
  411. Natural family planning effectiveness in Belgium.
  412. Natural family planning in the 1990s.
  413. Natural family planning.
  414. Natural family planning.
  415. Natural family planning. An alternative. [Planificacion familiar natural. Una alternativa.]
  416. Natural family planning: expanding options.
  417. Natural family planning: what health workers need to know.
  418. Natural killer cell activity is reduced in association with oral contraceptive use.
  419. The Navrongo Community Health and Family Planning Project.
  420. The Navrongo Community Health and Family Planning Project. Second annual report of the Navrongo Health Research Centre to the Rockefeller Foundation.
  421. Need for focus on men's perspective in family planning.
  422. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
  423. New Advantage 24 contraceptive gel claims 24-hour effectiveness. But proposed FDA rule could put N-9 products to the test.
  424. New contraceptive launched.
  425. New contraceptives in the 1990s.
  426. A new direction in population policy and family planning in the Islamic Republic of Iran.
  427. A new family planning ethos.
  428. New female contraceptive method, effective for 5 years. [Nuevo metodo anticonceptivo para la mujer, eficaz por 5 anos.]
  429. New frontiers in male contraception. Mellon Reproductive Biology Centers Meeting, Durham Hilton Hotel, Durham, NC, April 23-26, 1995.
  430. New progestin oral contraceptives and the female condom.
  431. News media relations for family planning organizations in Bangladesh: a needs assessment.
  432. The Nigeria Family Planning Facility Census.
  433. Non-contraceptive benefits of contraception. [Beneficios nao contraceptivos da contracepcao.]
  434. Noncompliance in adolescent oral contraceptive users.
  435. Norplant implants guidelines for family planning service programs. A problem-solving reference manual. 2nd ed.
  436. Norplant neuropathy: peripheral neurologic symptoms associated with subdermal contraceptive implants.
  437. Norplant, new method of contraception in Portugal. [Norplant, novo metodo da contracepcao em Portugal.]
  438. Norplant: an effective option for adolescent women. Subdermal implant contraception in adolescent women. Preliminary findings in 174 cases. [Norplant: opcion eficaz en mujeres adolescentes. Anticoncepcion con implantes subdermicos (Norplant) en mujeres adolescentes: observaciones preliminares en 174 casos.]
  439. Nutrition action plan of the child survival / family planning project: proposals made to the BASICS project, Senegal. [Plan d'action de nutrition du projet survie de l'enfant / planification familiale: propositions faites au projet BASICS Senegal.]
  440. On the needless hounding of a safe contraceptive.
  441. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
  442. Operations research in family planning in Lebanon: a study of the southern suburb of beirut.
  443. OR project dramatically increases contraceptive prevalence in Mali.
  444. Oral contraception -- benefits and risks. [Orale Kontrazeption -- Nutzen und Risiken.]
  445. Oral contraception and risk of cancer. Epidemiologic aspects of breast and gynecological cancers. [Contraception orale et risque de cancer. Aspects epidemiologiques des cancers mammaires et gynecologiques.]
  446. Oral contraception scare has reduced confidence in medical services.
  447. Oral contraceptive containing natural estradiol for premenopausal women.
  448. The oral contraceptive pill and cervical neoplasia [editorial]
  449. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
  450. Oral contraceptive side effects: where's the beef?
  451. Oral contraceptive therapy causes an increased and not a decreased resistance to APC [letter]
  452. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
  453. Oral contraceptive use among African American adolescents: individual and community influences.
  454. Oral contraceptive use and breast cancer risk among African-American women.
  455. Oral contraceptive use and risk of breast cancer in older women (New Zealand)
  456. Oral contraceptive use and risk of HIV transmission [letter]
  457. Oral contraceptive users may be at some increased risk of cervical carcinoma.
  458. Oral contraceptives and breast cancer risk among younger women.
  459. Oral contraceptives and breast cancer: a cooperative Italian study.
  460. Oral contraceptives and thrombosis -- current risk assessment. Recommendations from the Medical Product Agency. [P-piller och trombos -- aktuell riskbedomning. Rekommendationer fran Lakemedelsverket.]
  461. Oral contraceptives and venous thromboembolism [letter]
  462. Oral contraceptives and venous thromboembolism [letter]
  463. Oral contraceptives and venous thromboembolism [letter]
  464. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties.
  465. Oral contraceptives in perspective: benefit-risk evaluation. [P-piller i perspektiv -- nytta-riskvardering.]
  466. Oral contraceptives: an update.
  467. Oral contraceptives: APF takes a position. [Contraceptivos orais: APF toma posicao.]
  468. Outcome of pregnancies after failed hormonal postcoital contraception -- an interim report.
  469. Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods.
  470. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
  471. Ovarian function during low-dose oral contraceptive use.
  472. Overview: use of DHS data for family planning program design and evaluation.
  473. Pakistan Contraceptive Prevalence Survey 1994-95: basic findings.
  474. Past contraceptive method use and risk of ectopic pregnancy.
  475. Pelvic inflammatory disease in intrauterine contraceptive device users. [Pelvicna inflamaciona bolest kod primene intrauterinih kontraceptivnih ulozaka.]
  476. Perceptual mapping of service providers and contraceptive methods in Uttar Pradesh, India: key findings.
  477. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
  478. Perspectives on fertility and family planning in Egypt. Results of further analysis of the 1992 Egypt Demographic and Health Survey.
  479. Peru: the demand for family planning. [Peru: demanda de planificacion familiar.]
  480. Peruvian students' knowledge of, attitudes toward contraception improved by sex education programs.
  481. Pharmacology of oral contraceptives. [Pharmacologie des contraceptifs oraux.]
  482. Philippines. Improving training of family planning providers reduces costs.
  483. Philippines. Increasing the effectiveness of grassroots family planning and health volunteers.
  484. Philippines. Sustaining company-based family planning programs: a continuing partnership.
  485. Physicians' experience with Norplant implantable contraceptives in Finland.
  486. Physicians' responsibility toward birth control [letter]
  487. Pills, shots, implants, vaccines: can the elusive sperm be reined in? Male contraceptive research extremely slow, but promising.
  488. PocketGuide for family planning service providers.
  489. Policies affecting fertility and contraceptive use: an assessment of twelve Sub-Saharan countries.
  490. Policies and practices in postcoital contraceptive provision: a survey of general practitioners and hospital accident and emergency departments.
  491. Policy and programmatic use of DHS data: a tool for family planning program managers and analysts.
  492. Policy on family planning. [Politica de planificacion familiar. Ligne d'action concernant le planning familial.]
  493. The politics of blame: family planning, abortion and the poor.
  494. The popularity of the contraceptive Norplant has plummeted since last summer, and a researcher blames bad publicity caused by lawsuits.
  495. Population / family planning assessment in Benin.
  496. Population and birth control: an Anglican perspective.
  497. Population and family planning in Papua New Guinea, 1975-1995: a bibliography.
  498. Population and family planning: present and future -- moving toward a reproductive and sexual health agenda.
  499. Population and health in Senegal: annotated graphs. Fertility, family planning and maternal and child health: findings of the Demographic and Health Survey II [DHS], Senegal 1992 / 1993. [Population et sante au Senegal: graphiques commentes. Fecondite, planification familiale et sante de la mere et de l'enfant. Resultats de l'EDS-II Senegal 1992/93.]
  500. Population Council INOPAL II Peru, the Health Post Provider's "ABC of Family Planning". In-house project to produce an interactive counseling guide. September 1, 1994 - February 14, 1995. Final report.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.